Literature DB >> 15522311

IgM binding to injured tissue precedes complement activation during skeletal muscle ischemia-reperfusion.

Rodney K Chan1, Grace Ding, Nicola Verna, Shahrul Ibrahim, Sean Oakes, William G Austen, Herbert B Hechtman, Francis D Moore.   

Abstract

BACKGROUND: Skeletal muscle reperfusion injury is mediated by IgM natural antibodies and by complement activation, as shown by the attenuation of reperfusion injury seen in mice with no natural IgM [] and in mice deficient in complement C3 and C4 []. We postulate that tissue, when ischemic, expresses neoantigens to which preformed natural IgM antibodies bind, in turn producing harmful complement activation and reperfusion injury.
MATERIALS AND METHODS: C57Bl/6 mice were subjected to 2 h of tourniquet-induced hind limb ischemia followed by variable periods of reperfusion. Two hours of ischemia and 3 h of reperfusion produced severe muscle necrosis and edema. Deposition of IgM and C3 in tissue was assessed using immunohistochemistry on both frozen and Formalin-fixed tissue samples.
RESULTS: IgM binding to the endothelium and muscle bundles of the hind limb began during the ischemic period and continued throughout reperfusion up to 6 h. C3 deposition was not present during ischemia and, in contrast, began to appear at 1 h of reperfusion and increased progressively thereafter.
CONCLUSIONS: These data demonstrate that IgM binding to ischemic tissues precedes the damaging complement activation by a significant period of time. This has important therapeutic implications when considering anti-inflammatory therapy for reperfusion injury.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15522311     DOI: 10.1016/j.jss.2004.07.005

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  12 in total

1.  Immunoglobulin responses to a repeated bout of downhill running.

Authors:  A J McKune; L L Smith; S J Semple; B Mokethwa; A A Wadee
Journal:  Br J Sports Med       Date:  2006-08-18       Impact factor: 13.800

Review 2.  Clinical promise of next-generation complement therapeutics.

Authors:  Dimitrios C Mastellos; Daniel Ricklin; John D Lambris
Journal:  Nat Rev Drug Discov       Date:  2019-07-19       Impact factor: 84.694

3.  Direct orthotopic implantation of hepatic organoids.

Authors:  Vivian X Zhou; Macarena Lolas; Tammy T Chang
Journal:  J Surg Res       Date:  2016-12-29       Impact factor: 2.192

4.  Voluntary running protects against neuromuscular dysfunction following hindlimb ischemia-reperfusion in mice.

Authors:  Rebecca J Wilson; Joshua C Drake; Di Cui; Matthew L Ritger; Yuntian Guan; Jarrod A Call; Mei Zhang; Lucia M Leitner; Axel Gödecke; Zhen Yan
Journal:  J Appl Physiol (1985)       Date:  2018-11-15

5.  Natural IgM anti-leukocyte autoantibodies attenuate excess inflammation mediated by innate and adaptive immune mechanisms involving Th-17.

Authors:  Peter I Lobo; Amandeep Bajwa; Kailo H Schlegel; John Vengal; Sang J Lee; Liping Huang; Hong Ye; Umesh Deshmukh; Tong Wang; Hong Pei; Mark D Okusa
Journal:  J Immunol       Date:  2012-01-18       Impact factor: 5.422

6.  Sca-1 influences the innate immune response during skeletal muscle regeneration.

Authors:  Kimberly K Long; Grace K Pavlath; Monty Montano
Journal:  Am J Physiol Cell Physiol       Date:  2010-12-01       Impact factor: 4.249

7.  Postischemic treatment with ethyl pyruvate prevents adenosine triphosphate depletion, ameliorates inflammation, and decreases thrombosis in a murine model of hind-limb ischemia and reperfusion.

Authors:  Robert S Crawford; Hassan Albadawi; Marvin D Atkins; John J Jones; Mark F Conrad; William G Austen; Mitchell P Fink; Michael T Watkins
Journal:  J Trauma       Date:  2011-01

8.  Loss of Id3 (Inhibitor of Differentiation 3) Increases the Number of IgM-Producing B-1b Cells in Ischemic Skeletal Muscle Impairing Blood Flow Recovery During Hindlimb Ischemia.

Authors:  Victoria Osinski; Prasad Srikakulapu; Young Min Haider; Melissa A Marshall; Vijay C Ganta; Brian H Annex; Coleen A McNamara
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-11-23       Impact factor: 8.311

9.  Restoration of skeletal muscle ischemia-reperfusion injury in humanized immunodeficient mice.

Authors:  Eric G Sheu; Sean M Oakes; Cyrus Ahmadi-Yazdi; Jalil Afnan; Michael C Carroll; Francis D Moore
Journal:  Surgery       Date:  2009-08       Impact factor: 3.982

10.  Attenuation of the effects of rat hemorrhagic shock with a reperfusion injury-inhibiting agent specific to mice.

Authors:  Cyrus Ahmadi-Yazdi; Brian Williams; Sean Oakes; Francis D Moore
Journal:  Shock       Date:  2009-09       Impact factor: 3.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.